Company Filing History:
1 out of 10 
1 out of 2 Years Active: 2024
Title: Innovator Spotlight: Hyun Jeung CHOI
Introduction: Hyun Jeung CHOI is a notable inventor based in Seoul, South Korea. With a strong focus on biological research, he has made significant contributions to the field through his innovative methods. His work is particularly influential in the area of nucleic acid analysis, helping to enhance the understanding and application of genetic information in clinical settings.
Latest Patents: Hyun Jeung CHOI holds one patent titled "Method for determining nucleic acid quality of biological sample." This invention relates to a method for assessing the quality of DNA in biological samples. More specifically, it utilizes quantitative polymerase chain reaction (PCR) techniques with specially designed primers that amplify target genes. His method also includes protocols for preparing these primers and standardizing the detection of any target gene mutations based on the established DNA quality. This invention facilitates objective evaluation in gene analysis and provides consistent and reliable results for gene mutation expression ratios, which is essential for clinical research and companion diagnostics.
Career Highlights: Throughout his career, Hyun Jeung CHOI has worked with several prominent companies, including Gencurix Inc and Logone Bio Convergence Research Foundation. His expertise in the field has allowed him to contribute valuable insights and advancements in biotechnology, specifically in genomic analysis.
Collaborations: Hyun Jeung CHOI has collaborated with various professionals in his field, including notable colleagues such as Young Kee Shin and Jin Ju Kim. These collaborations have enriched his research perspective and led to fruitful developments in his projects.
Conclusion: Hyun Jeung CHOI stands out as a significant inventor whose contributions to the examination of nucleic acids have opened new avenues in medical research and diagnostics. His patented method not only enhances the understanding of DNA quality but also solidifies his position as a leading innovator in the biotechnological landscape.